Apo-Sertraline 100mg tablets

Apo-Sertraline is a generic version of the selective serotonin reuptake inhibitor (SSRI) medication sertraline, used primarily in the treatment of depression and anxiety disorders. The 'APO' prefix signifies that this medication is part of the Apotex product line, a major player in the global pharmaceutical market specializing in high-quality, affordable generic medicines.

Originally developed by the Canadian pharmaceutical giant Apotex Inc., the brand represents a significant portion of the generic drug market in North America and Australasia. While the brand originated in Canada, its manufacturing footprint is global, involving facilities in Canada, India, and Mexico to ensure consistent supply for international markets including Australia, as seen in the pharmacy labeling in the image. Although Apotex was founded as a family-owned Canadian enterprise by Barry Sherman, it was acquired by the global investment firm SK Capital Partners in early 2023, marking a transformation into a private equity-backed global pharmaceutical powerhouse.